Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2770 participants.

Also called NCT06095765

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 2,770 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06095765
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06095765. Randomized; single masking; primary purpose prevention. Start 2024-01-29 (actual); primary completion 2027-11-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
Acronym
COL BE PCI
Intervention (Drug)
Colchicine 0.5 MG Oral Tablet
Intervention (Drug)
Placebo
Lead sponsor
AZ Sint-Jan AV (class: other)
Collaborator
University Hospital, Ghent (class: other)
Collaborator
Belgium Health Care Knowledge Centre (class: other government)

Record details

Record id
cardio:ct-nct06095765
Content hash
a303092228f03c2a53dd5509e1f42b0f1858e8939c07f7fb997bf834bc80213e